Log In
Print this Print this


Also known as: clindamycin

  Manage Alerts
Collapse Summary General Information
Company Uluru Inc.
DescriptionClindamycin formulated using ResiDerm topical delivery system
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne; Treat mild to moderate acne
Regulatory Designation
PartnerAstellas Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today